Covishield vaccine

Poonawalla was speaking at a felicitation ceremony organised for him by the Mahratta Chamber of Commerce, Industries and Agriculture in Pune. Serum Institute of India’s chairman and MD Cyrus Poonawalla on Monday said his company works with…

Adar Poonawalla, chief executive officer, SII, tweeted on Friday and said the company had supplied 1.25 billion doses of Covishield in India and the government had enough data for this permission. Serum Institute of India (SII) has sought…

Oxford University has found that a booster dose of the Coronavirus vaccine developed by AstraZeneca is successful in increasing the levels of antibodies against the new variant of coronavirus Omicron. Offering a glimpse of hope, a study at…

As SII's Covid-19 vaccine, Covishield, was not yet accepted in these countries students have to incur substantial quarantine costs. Adar Poonawalla, CEO of Serum Institute of India (SII), on Thursday announced that he had created a Rs…

The study highlights the impact of protection against Covid-19 by Covishield vaccine by analyzing its effect on fresh infections and deaths. ‘The Armed Forces Medical College, and the medical directorates of Army, Navy and Air Force…

The study took place when the nation was struggling with the second wave of COVID-19 (Photo: Covishield/ Reuters)A large-scale study by the armed forces showed nearly 93 per cent reduction in Covid infections in those who have taken…

The EU drug regulator has only approved four Coronavirus vaccines namely- Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson.Amidst multiple setbacks from European drug regulators, Covishield vaccine, in a significant boost,…

Amidst countries facing acute Coronavirus shortage, certified and definite research on combining two different vaccine doses could help countries vaccinate populations more effectively against the virus.As vaccines have become a part of our…

By PTI NEW DELHI: One in four people experience mild, short lived systemic side effects after receiving either the COVID-19 preventive by Pfizer or AstraZeneca vaccine -- known as Covishield in India -- with headache,…